ACUMEN PHARMACEUTICALS INC (ABOS) Stock Income Statement
NASDAQ:ABOS - Nasdaq - US00509G2093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 126.23M | 114.00M | 61.00M | 45.24M | 19.58M | |||
| Research and Development | 106.61M | N/A | 42.32M | 32.36M | 12.31M | |||
| Selling, General, and Administrative Expenses | 20.00M | 20.00M | 19.00M | 12.88M | 7.28M | |||
| Operating Income | -126.23M | -114.00M | -61.00M | -45.24M | -19.58M | |||
| Interest Income/Expense | 10.52M | N/A | 8.85M | 2.39M | 80.00K | |||
| Other Income/Expense | -163.00K | 12.00M | -80.00K | -10.00K | -81.11M | |||
| Income Before Taxes | -116.72M | -102.00M | -52.00M | -42.86M | -100.61M | |||
| Net Income | -116.72M | -102.00M | -52.00M | -42.86M | -100.61M | |||
| EBITDA | -126.05M | -113.82M | -60.82M | -45.21M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.93 | -1.71 | -1.08 | -1.06 | -5.02 | |||
| Non GAAP EPS | -1.94 | -1.71 | -1.08 | -1.06 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD